Evidence map›Paper›PMID 37644679›Full record

ArticleJournal of Korean medical science2023

Clinical Effectiveness of Tetracycline-Class Agents Based Regimens in Patients With Carbapenem-Resistant

Si-Ho Kim, Yu Mi Wi, Kyong Ran Peck

Registry-linked trialOpen access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of Korean medical science, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06440304 (Therapeutic Strategies for Carbapenem-Resistant Acinetobacter Baumannii Infections), which is not on this map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
0.4field-weighted citation impact, top 49% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06440304 phase4recruitingnot on this mapstarted 2025, after this paper: background citation

Therapeutic Strategies for Carbapenem-Resistant Acinetobacter Baumannii Infections: Study Protocol

TypeinterventionalSponsorClinical Hospital Centre ZagrebRan2025 to 2027Enrolled108ConditionsInfections, Bacterial, Sepsis BacterialArmsFosfomycin, Eravacycline, ampicillin/sulbactam
3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 4 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. New Insights intoPathogens (Basel, Switzerland) · 2026
    Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Si-Ho KimDivision of Infectious Diseases, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine, Changwon, Korea.ORCID https://orcid.org/0000-0001-7763-8940
Yu Mi WiDivision of Infectious Diseases, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine, Changwon, Korea. yumi.wi@samsung.com.ORCID https://orcid.org/0000-0003-3625-3328
Kyong Ran PeckDivision of Infectious Diseases, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. krpeck@skku.edu.ORCID https://orcid.org/0000-0002-7464-9780
Samsung (South Korea) · KRSamsung Medical Center · KR

Funding

Sungkyunkwan University School of Medicine Samsung Changwon Hospital
6 · The paper itself

Abstract

This study evaluated the clinical outcome of carbapenem-resistant

Indexed as

Acinetobacter baumanniiBacteremiaAnti-Bacterial AgentsCarbapenemsColistinHumansRetrospective StudiesTetracyclineTetracyclinesTreatment OutcomeAnti-Bacterial AgentsCarbapenemsColistinTetracyclineTetracyclinesCarbapenem-ResistanceExtensively Drug ResistantMinocyclineTetracyclinesTigecycline

Identifiers

PMID37644679
PMCPMC10462474
OpenAlexW4385649041

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.